SavedAdd your journal

Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2009 / Cilt: 14 - Sayı: 3

A case of methicillin-sensitive Staphylococcus aureus (MSSA) meningitis-cerebritis treated with linezolid

Linezolid ile tedavi edilen metisiline duyarlı Staphylococcus aureus (MSSA)’un etken olduğu menenjit-serebrit olgusu

Dilek ARMAN
Nuran SARI
Ergüt Büşra SEZER
Nesrin ATA
Murat DİZBAY
Kenan HIZEL
Fikret İLERİ
Fatma ULUTAN
Pages
139–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient recovered successfully with the treatment, and no recurrence or complication was detected during the two-year follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Staphylococcal meningitis frequently develops in the presence of risk factors, and difficulties in the treatment may be seen.
📊
Key Findings & Data:We report herein a 43-year-old male patient with meningitis-cerebritis secondary to otitis-mastoiditis, which developed three months after frontal sinus and nasal polyp operation due to Samter's syndrome.
💡
Conclusion & Impact:The patient recovered successfully with the treatment, and no recurrence or complication was detected during the two-year follow-up.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Erişkin · Erkek · Staphylococcus aureus

Abstract

Staphylococcal meningitis frequently develops in the presence of risk factors, and difficulties in the treatment may be seen. We report herein a 43-year-old male patient with meningitis-cerebritis secondary to otitis-mastoiditis, which developed three months after frontal sinus and nasal polyp operation due to Samter's syndrome. A methicillin-sensitive Staphylococcus aureus was isolated from the cerebrospinal fluid. The patient was treated with linezolid 2 x 600 mg/day, 15 days intravenously followed by 25 days peroral. The patient recovered successfully with the treatment, and no recurrence or complication was detected during the two-year follow-up.

Özet

Stafilokoklarin etken olduğu menenjitler sıklıkla risk faktörleri varlığında gelişen ve tedavilerinde güçlüklerin söz konusu olabildiği klinik tablolardır. Burada 43 yaşında Samter sendromu tanısı ile izlenen erkek hastada frontal sinüs ve nazal polip operasyonundan üç ay sonra gelişen otit-mastoidite sekonder menenjit-serebrit tablosu sunulmuştur. Beyin omurilik sıvısı kültüründe metisiline duyarlı Staphylococcus aureus izole edilen hasta, 15 gün intravenöz daha sonra 25 gün oral linezolid 2 x 600 mg/gün ile başarılı bir şekilde tedavi edilmiş; iki yıllık takip boyunca herhangi bir komplikasyon ya da nüks saptanmamıştır.

🔖

Cite This Article

ARMAN, D., SARI, N., SEZER, E. B., ATA, N., DİZBAY, M., HIZEL, K., İLERİ, F., ULUTAN, F. (2009). A case of methicillin-sensitive Staphylococcus aureus (MSSA) meningitis-cerebritis treated with linezolid. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 14 - Sayı: 3, 139–143. https://ajindex.com/articles/208438

References (13)

  1. Ntziara F, Falagos ME. Linezolid for the treatment of patients with central nervous system infections. Ann Pharmacother 2007;41:296-308
  2. Gill CJ, Murphy MA, Hamer DH. Treatment of Staphylococ cus epidermidis ventriculo-peritoneal shunt infection with li nezolid. Eur J Infect 2002;45:l 29-32
  3. Moellering RC. Linezolid: The first oxazolidinone antimicro bial. Ann Intern Med 2003;138:135-42
  4. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, et al. Linezolid versus teicoplanin in treatment of gram positive infections in critically ill: A randomized, double blind, multicentre study. J Antimicrob Chemother 2004;53: 345-55
  5. Myrianthefs P, Markantonis SL, Vlachos K, Anagnostaki M, Boutzouka E, Panidis D, et al. Serum and cerebrospinal flu id concentration of linezolid in neurosurgical patients. Anti microb Agents Chemother 2006;50:3971 -6
  6. Rupprecht TA, Pfister HW. Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol 2005;12:536-42
  7. Karaoğlan I, Namıduru M, Tanrıverdi M. Linezolid ile teda vi edilen metisiline dirençli Staphylococcus epidermidis 'in et ken olduğu ventriküloperitoneal şant infeksiyonu olgusu. KLİMİK Derg 2007;20:61-2
  8. Tunkel AR, Scheld WM. Acute meningitis. Approach to the patient with central nervous system infection. In: Mandell CL, Bennett JE, Dolin R (eds). Principles and Practice of In fectious Disease. 6th ed. Philadelphia: Churchill Livingstone, 2005:1079-121
  9. Chang WN, Lu CH, Wu JJ, Chang HW, Tsai YC, Chen FT, et al. Staphylococcus aureus meningitis in adults: A clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Clinical and epidemiological study. Infection 2001;29:245-50
  10. Lutsar I, McCracken GH, Friedland İR. Antibiotic pharma codynamics in cerebrospinal fluid. Gin Infect Dis 1998;27: 1117-27
  11. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. IDSA Guidelines. Gin Infect Dis 2004; 39:1267-84
  12. Beek VD, Gans J, Spanjaad L, Vermeulen M, Dankert J. An tibiotic guidelines and antibiotic use in adult bacterial me ningitis in the Netherlands.J Antimicrob Chemother 2002; 49:661-6
  13. Chaudhuria A, Martin PM, Kennedy PGE, Seaton RA, Porte gies P, Bojar M, et al. EFNS guideline on the management of community-acquired bacterial meningitis: Report of an EFNS Task Force on acute bacterial meningitis in older child ren